Srisala Navaratnam appears on the Manitoba Compensation Disclosure with a 2024 disclosed compensation of $415,630. Srisala is listed as President and CEO at CancerCare Manitoba, in the Health sector.
Srisala has been disclosed in 4 of the 5 years between 2020 and 2024. Their reported compensation has grown from $369,084 in 2020 to $415,630 in 2024 — a 12.6% change over 4 years.
Within the Health sector that year, Srisala's $415,630 placed them in the 99th percentile (sector average: $124,659). Across the entire 2024 disclosure, this places them in the top 1% of all disclosed earners that year. Over their time on the list, Srisala moved to CancerCare Manitoba in 2021.
From 2025, Manitoba publishes first initials only, so Srisala may still be on the list under an initial; no single record could be matched to them.
The interactive timeline and year-by-year breakdown below show every year Srisala has been disclosed under the Manitoba Public Sector Compensation Disclosure.
Data sourced from the Manitoba Public Sector Compensation Disclosure. This site is independent and not affiliated with any government. Always verify against the official source.
$416K
Current Salary
2024
4
Years on List
2020–2024
+12.6%
Salary Growth
2020–2024
-$106,687 vs previous year
Sector avg $124,659 · Range $85K\u2013$1.4M
Earns more than 100% of disclosed employees.
Showing total compensation
2024
President and CEO
CancerCare Manitoba
$415,630
-$106,687
2023
President and CEO
CancerCare Manitoba
$522,317
+$153,320
2021
President and CEO
CancerCare Manitoba
$368,997
-$87
2020
PRESIDENT AND CEO
Cancer Care Manitoba
$369,084